Meta Pixel

News and Announcements

Mad Paws nominated for Startcon’s startup of the year award

  • Published November 21, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates
  • Mad Paws are delighted to announce they have been nominated for Startup of the Year by Startcon.
  • Mad Paws are one of five finalists across 17 categories.
  • The startup,  has doubled its workforce in the last year alone, with 33 employees, and has raised $6.1 million.
Mad Paws are delighted to announce they have been nominated for Startup of the Year by Startcon, Australia’s largest startup event.
With over 500 nominations, Startcon have now narrowed it down to the top 5 finalists across 17 categories. The awards recognises the top up-and-coming startups, entrepreneurs and tech companies in the APAC region.
Voting closes on November 23rd: https://www.startcon.com/vote
Mad Paws is also pleased to announce its investment round of $1,000,000 is 70% filled, with good ongoing conversations.

 

About Mad Paws

Mad Paws, Australia’s largest Pet Sitting marketplace, connects Pet Owners with 15,000 local, vetted, and insured Pet Sitters and Dog Walkers.

Mad Paws has scaled rapidly across Australia and is a proud partner of Qantas, who is also an investor alongside Equity Venture Partners and Macdoch Ventures.

With an awesome team, Mad Paws recently ranked #14 on LinkedIn’s Top 25 Australian Startups to work for 2018.

Register Interest

 

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now